Heterocyclic compounds useful as pdk1 inhibitors
US-2024294524-A1 · Sep 5, 2024 · US
Van Vloten Kurt is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Van Vloten Kurt |
| Total patents | 7 |
| First publication | Nov 17, 2016 |
| Latest publication | Sep 5, 2024 |
Publications ranked by popularity score, then publication date.
US-2024294524-A1 · Sep 5, 2024 · US
US-2023113598-A1 · Apr 13, 2023 · US
US-2021070752-A1 · Mar 11, 2021 · US
US-2019119268-A1 · Apr 25, 2019 · US
US-10030016-B2 · Jul 24, 2018 · US
US-9546165-B2 · Jan 17, 2017 · US
US-2016331756-A1 · Nov 17, 2016 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Millennium Pharm Inc | 7 |
| Sunesis Pharmaceuticals Inc | 5 |
| Viracta Therapeutics Inc | 2 |
| Arndt Joseph | 1 |
| Chan Timothy | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D471/04 | 7 |
| C07D413/14 | 7 |
| C07D407/14 | 7 |
| A61P35/04 | 7 |
| A61P35/02 | 7 |